pharmaceutical investing Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
pharmaceutical investing Pantera Minerals Limited High-Grade Antimony to 3.9% Sb and Extensive Soil Anomalies Confirm Priority Drill Targets
pharmaceutical investing Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
pharmaceutical investing TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
pharmaceutical investing Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
pharmaceutical investing ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart maintains high levels of viral suppression in long-acting HIV treatment regimen
pharmaceutical investing U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
pharmaceutical investing Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
pharmaceutical investing Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
pharmaceutical investing Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
pharmaceutical investing Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
pharmaceutical investing Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer
pharmaceutical investing Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
